Latest news for Doosan Fuel Cell (OTC:DOOSF) Stock

Doosan Fuel Cell is a South Korea based company engaged in manufacturing of electric motors and generators.

DOOSAN FUEL CELL CO LTD by Doosan Fuel Cell Co Ltd.

Doosan Fuel Cell

TD Cowen analyst John Kernan maintains Skechers USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) with a Buy and raises the price target from $77 to $79.

News

Price Target

Analyst Ratings

TD Cowen Maintains Buy on Skechers USA, Raises Price Target to $79

Citigroup analyst Jon Tower maintains Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Neutral and lowers the price target from $85 to $80.

SBUX

Citigroup Maintains Neutral on Starbucks, Lowers Price Target to $80

Baird analyst Mircea Dobre maintains Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) with a Neutral and raises the price target from $58 to $67.

Baird Maintains Neutral on Terex, Raises Price Target to $67

TD Cowen analyst Marc Bianchi maintains Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) with a Buy and lowers the price target from $47 to $45.

TD Cowen Maintains Buy on Halliburton, Lowers Price Target to $45

Citigroup analyst Itay Michaeli maintains Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) with a Neutral and lowers the price target from $119 to $108.

Citigroup Maintains Neutral on Autoliv, Lowers Price Target to $108

Truist Securities analyst Joon Lee maintains argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) with a Buy and raises the price target from $480 to $540.

ARGX

Truist Securities Maintains Buy on argenx, Raises Price Target to $540

TD Cowen analyst Marc Bianchi maintains Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Buy and raises the price target from $62 to $64.

TD Cowen Maintains Buy on Schlumberger, Raises Price Target to $64

Citigroup analyst Keith Horowitz maintains State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) with a Neutral and raises the price target from $85 to $90.

Citigroup Maintains Neutral on State Street, Raises Price Target to $90

Truist Securities analyst Brandon King maintains Wintrust Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) with a Buy and raises the price target from $107 to $118.

WTFC

Truist Securities Maintains Buy on Wintrust Finl, Raises Price Target to $118

Truist Securities analyst Brandon King maintains Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) with a Buy and raises the price target from $74 to $88.

Truist Securities Maintains Buy on Western Alliance, Raises Price Target to $88

Brookline Capital analyst Kemp Dolliver initiates coverage on iBio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#AMEX">IBIO</a>) with a Buy rating and announces Price Target of $3.6.

Initiation

IBIO

Brookline Capital Initiates Coverage On iBio with Buy Rating, Announces Price Target of $3.6

Glass House Brands Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GLASF#OTC">GLASF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GHBWF#OTC">GHBWF</a>) announced on Monday that a California court dismissed a lawsuit accusing the cannabis giant of involvement in the illegal cannabis market. The Superior Court of California in Los Angeles County ruled in favor of Glass House, dismissing the case with prejudice and awarding costs against the plaintiff, Catalyst Cannabis Co.
<h3 class="wp-block-heading">Court Rejects Catalyst&#8217;s Claims Against Glass House</h3>
The dismissed suit, filed by Long Beach-based retail chain 562 Discount Med Inc., operating as Catalyst Cannabis Co., alleged unfair competition by Glass House. The court, however, <a href="https://www.benzinga.com/markets/cannabis/24/06/39492317/la-court-judge-set-to-dismiss-major-lawsuit-against-californias-top-cannabis-cultivator" target="_blank" rel="noreferrer noopener">ruled on June 25</a>, that the imposition of an injunction as requested by Catalyst would encroach on the regulatory duties of administrative agencies, deeming any such enforcement as overly burdensome. Consequently, the case concluded last Monday, with a judgment favoring Glass House, which also included an order for Catalyst to cover the legal costs, <a href="https://www.globenewswire.com/en/news-release/2024/07/22/2916451/0/en/Glass-House-Brands-Announces-Court-Dismissal-of-Catalyst-Lawsuit.html" target="_blank" rel="noreferrer noopener">according</a> to a press release from Glass House.
This dismissal comes after a year of legal battles that began in June 2023, <a href="https://www.benzinga.com/markets/cannabis/23/06/32840939/weed-trafficking-plot-california-co-sues-competitor-over-alleged-black-market-profiteering" target="_blank" rel="noreferrer noopener">when Catalyst accused Glass House</a> of diverting legally produced cannabis to illegal markets. Glass House responded by countersuing Catalyst and its principals for defamation, <a href="https://www.benzinga.com/markets/cannabis/24/05/38951302/californias-corporate-weed-beef-glass-house-withdraws-defamation-suit-against-catalyst-cannabis" target="_blank" rel="noreferrer noopener">a case Glass House voluntarily dismissed last May</a>, citing concerns over Catalyst&#8217;s financial instability and potential harassment.
<h3 class="wp-block-heading">Glass House Defends Compliance California's Regulations</h3>
Glass House&#8217;s adherence to California's METRC system for monitoring licensed <a href="http://benzinga.com/cannabis">cannabis</a> operations has been a cornerstone of their defense. Despite Catalyst&#8217;s CEO, Elliot Lewis, <a href="https://www.benzinga.com/markets/cannabis/24/06/39492317/la-court-judge-set-to-dismiss-major-lawsuit-against-californias-top-cannabis-cultivator" target="_blank" rel="noreferrer noopener">criticizing the court&#8217;s decision as a sidestep</a>, the ruling points to the complexity of enforcing such allegations and notes that regulatory responsibilities fall to the state's Department of Cannabis Control (DCC).
Glass House continues to emphasize its commitment to compliance and operational integrity amidst <a href="https://www.benzinga.com/markets/cannabis/24/07/39731486/illegal-marijuana-grows-left-6-000-pounds-of-waste-in-california-state-parks-helicopters-were-ne" target="_blank" rel="noreferrer noopener">California&#8217;s cannabis industry-wide hurdles</a>.
GLASF Price Action GLASF's shares were trading 1.23% higher at $7.00 per share at the time of this writing around 10:50 AM ET Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39798378/california-looks-to-address-growing-environmental-concerns-of-cannabis-vape-pen-disposal">California Looks To Address Growing Environmental Concerns Of Cannabis Vape Pen Disposal</a></li>
</ul>

Cannabis

Government

Regulations

Legal

GHBWF

GLASF

Legal Win For Glass House: LA Court Dismisses Lawsuit Alleging Illegal Cannabis Dealings

Truist Securities analyst Neal Dingmann maintains Vital Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTLE#NYSE">VTLE</a>) with a Buy and lowers the price target from $75 to $68.

VTLE

Truist Securities Maintains Buy on Vital Energy, Lowers Price Target to $68

Truist Securities analyst Neal Dingmann maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Buy and raises the price target from $53 to $54.

VNOM

Truist Securities Maintains Buy on Viper Energy, Raises Price Target to $54

Citigroup analyst Patrick Cunningham maintains PPG Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) with a Buy and lowers the price target from $145 to $144.

Citigroup Maintains Buy on PPG Indus, Lowers Price Target to $144

Truist Securities analyst Brandon King maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Hold and raises the price target from $62 to $70.

TCBI

Truist Securities Maintains Hold on Texas Capital Bancshares, Raises Price Target to $70

Argus Research analyst Chris Graja maintains Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) with a Buy and raises the price target from $70 to $72.

Argus Research Maintains Buy on Kroger, Raises Price Target to $72

Trading Ideas

ASML

Live On CNBC, Steve Weiss Announces Sold ASML

Truist Securities analyst Neal Dingmann maintains Sitio Royalties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STR#NYSE">STR</a>) with a Buy and lowers the price target from $33 to $31.

Truist Securities Maintains Buy on Sitio Royalties, Lowers Price Target to $31

Truist Securities analyst Neal Dingmann maintains SM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) with a Hold and lowers the price target from $49 to $46.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Doosan Fuel Cell

News

Latest news for Doosan Fuel Cell (OTC:DOOSF) Stock